Articles From: 2015/1/12 - INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Alcobra, Ltd. to 2015/1/11 - GES Has Big Plans For PCMA's Convening Leaders


2015/1/12
Glancy Binkow & Goldberg LLP reminds investors of Alcobra, Ltd.
Sign-up for 2015/1/12 - INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Alcobra, Ltd. investment picks
2015/1/12
1-800-FLOWERS.COM, Inc. (NASDAQ: FLWS), the world’s leading florist and gift shop, today announced that a member of its senior management team will present at the Noble Financial Capital Markets’ “D2” 11 th Annual Equity Conference at Club Med in Sandpiper Bay, Florida, on Monday, January 19, 2015 at 3:30 pm Eastern Time.
Sign-up for 2015/1/12 - 1-800-FLOWERS.COM, Inc. To Present At Noble Financial Capital Markets’ “D2” 11th Annual Equity Conference investment picks
2015/1/12
Accenture (NYSE:ACN) announced that Accenture Duck Creek Policy is now in production at global insurer Zurich, supporting its general insurance business in the United Kingdom.
Sign-up for 2015/1/12 - Zurich Insurance PLC Deploys Accenture Duck Creek Policy for Core Processing of Multiple Lines of Business in the UK investment picks
2015/1/12
Logility Inc., a leading supplier of advanced retail planning and supply chain optimization solutions, today announced the availability of Logility Voyager Retail Optimization V5.4. This latest release extends the value of an integrated retail and supply chain platform and delivers new merchandise planning views, extended allocation functionality and robust assortment planning capabilities.
Sign-up for 2015/1/12 - Logility Announces Logility Voyager Retail Optimization V5.4 investment picks
2015/1/12
Company is committed to offsetting dilution from stock options 50 acres of excess, undeveloped land in Edmonton conditionally sold Declares quarterly cash dividend of $0.14 per share (All figures are presented in US dollars unless otherwise noted) VANCOUVER , Jan.
Sign-up for 2015/1/12 - Ritchie Bros. Board authorizes share repurchase program; Company announces disposition of excess land in Edmonton investment picks
2015/1/12
Global Partners LP (NYSE: GLP) today announced that Daphne H.
Sign-up for 2015/1/12 - Global Partners to Participate in One-on-One Meetings at the UBS MLP One-on-One Conference on January 13 investment picks
2015/1/12
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168486&ProfileId=051205&sourceType=1 HOUSTON, TX --
Sign-up for 2015/1/12 - Equus Dispositions Yield $3.6 Million in Cash and a $0.9 Million Note investment picks
2015/1/11
By Bradley Hope After years of fighting for more trading to come back onto stock exchanges, Nasdaq OMX Group Inc. (NDAQ) is considering joining the dark side.
Sign-up for 2015/1/11 - Nasdaq looks to operate dark pools for banks investment picks
2015/1/11
2014 Preliminary Estimates: Total revenues of $445 to $450 million, a 43% increase over 2013 (at midpoint) GAAP net income of $36 to $38 million, a 19% increase over 2013 (at midpoint) Adjusted net income of $53 to $55 million, a 49% increase over 2013 (at midpoint) 2015 Forecast: Total revenues of $510 to $540 million, a 17% increase over 2014 (at midpoints) GAAP net income of $50 to $60 million, a 49% increase over 2014 (at midpoints) Adjusted net income of $60 to $70 million, or 20% increase over 2014 (at midpoints) GAITHERSBURG, Md., Jan.
Sign-up for 2015/1/11 - Emergent BioSolutions Announces Preliminary 2014 Financial Results and Provides 2015 Financial Outlook investment picks
2015/1/11
EMERYVILLE, Calif., Jan.
Sign-up for 2015/1/11 - Adamas Pharmaceuticals Provides Review of 2014 and Previews Upcoming Business Drivers investment picks
2015/1/11
Dublin-based Shire plc on Sunday said it will acquire NPS Pharmaceuticals in a $5.2 billion deal, uniting two companies that focus on so-called orphan drugs and rare diseases.
Sign-up for 2015/1/11 - UPDATE: Ireland-based Shire to buy NPS for $5.2 billon, or $45 a share investment picks
2015/1/11
HILDEN , Germany and BEVERLY, Massachusetts , January 11, 2015 /PRNewswire/ -- Enzymatics products used in 80% of all global NGS sequencing reactions Strengthens QIAGEN's universal NGS product offering and strategy to offer complete NGS workflows from sample to insight Adds comprehensive R&D, manufacturing, formulation and analytical capabilities in enzymology Strategic partnership formed with ArcherDX, including technology and distribution rights to proprietary Archer NGS panel technology QIAGEN reaffirms fourth-quarter and full-year 2014 adjusted net sales guidance; charges to be taken related to acquisition and other restructuring activities QIAGEN N.V. (NASDAQ: QGEN, Frankfurt Prime Standard QIA) today announced the acquisition of the Enzyme Solutions Unit of Enzymatics, a world leader in the development, manufacturing, and OEM supply of enzymes essential
Sign-up for 2015/1/11 - QIAGEN Acquires Enzymatics Enzyme Solutions Unit, a Leading Enabler of NGS Applications investment picks
2015/1/11
XenoPort (NASDAQ:XNPT) today reported an update on prescription trends and further development of HORIZANT ® (gabapentin enacarbil) Extended-Release Tablets, including feedback from the U.S. Food and Drug Administration (FDA) on development for treatment of alcohol use disorder (AUD). HORIZANT prescription trend highlights include: The number of nation-wide prescribed tablets for the 13 weeks ending December 19, 2014 was 1,256,082, an increase of 18% compared to the prior 13 weeks ending September 19, 2014 and an increase of 95% over the 13-week period ending December 20, 2013.* The rolling four-week average of prescribed tablets for the week ending December 19, 2014 was 100,742.* The current wholesale acquisition cost (WAC) price is $7.69 per tablet.
Sign-up for 2015/1/11 - XenoPort Provides Highlights of HORIZANT Prescription Trends and Update on Development for Alcohol Use Disorder investment picks
2015/1/11
By Jonathan D.
Sign-up for 2015/1/11 - Shire to buy NPS Pharmaceuticals for $5.2 billion investment picks
2015/1/11
DUBLIN and BEDMINSTER, New Jersey , January 11, 2015 /PRNewswire/ -- Transaction valued at $5.2 billion Enhances growth profile Shire plc (LSE: SHP, NASDAQ: SHPG) and NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) today announced that the companies have entered into a merger agreement pursuant to which Shire will acquire all the outstanding shares of NPS Pharma for $46.00 per share in cash, for a total consideration of approximately $5.2 billion .
Sign-up for 2015/1/11 - PLShire to Acquire NPS Pharma as Further Step in Building a Leading Biotech investment picks
2015/1/11
Affymetrix, Inc. (NASDAQ: AFFX) will be highlighting several new genotyping arrays at the 2015 Plant and Animal Genome Conference (PAGXXIII) for applications in breeding and routine analysis.
Sign-up for 2015/1/11 - Affymetrix Expands Portfolio of Axiom Genotyping Arrays For Agrigenomics with New Offerings for Porcine and Equine Studies investment picks
2015/1/11
Transaction Highlights: New industry-leading company expected to capitalize on the HBV global market opportunity.
Sign-up for 2015/1/11 - Tekmira Pharmaceuticals and OnCore Biopharma Announce Merger Agreement to Create Leading Global Hepatitis B Virus Company investment picks
2015/1/11
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1166467&ProfileId=051205&sourceType=1 WALTHAM, MA --
Sign-up for 2015/1/11 - Profitect Signs Reseller Agreement With Zebra Technologies investment picks
2015/1/11
ImmunoGen, Inc .
Sign-up for 2015/1/11 - ImmunoGen, Inc. Announces 2015 Outlook for Product Pipeline investment picks
2015/1/11
By Shawn Langlois, MarketWatch Stock volatility picks up as earnings season begins LOS ANGELES (MarketWatch) -- Gold prices rallied on Monday, adding on to last week's 2.5% advance as the volatility that has gripped the stock markets showed no sign of calming.
Sign-up for 2015/1/11 - Gold prices build on last week's momentum investment picks
2015/1/11
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch)--Big banks and other financial companies will dominate the start of earnings season this week, as the sector is expected to underperform the broader S&P 500 index in a quarter where expectations have already dropped considerably.
Sign-up for 2015/1/11 - UPDATE: Banks kick off low-expectation earnings season investment picks
2015/1/11
NEW YORK and BOSTON, Jan.
Sign-up for 2015/1/11 - Keryx Biopharmaceuticals Announces Transition of Leadership investment picks
2015/1/11
By John D.
Sign-up for 2015/1/11 - GM readies electric rival to Tesla investment picks
2015/1/11
By MarketWatch, MarketWatch SAN FRANCISCO (MarketWatch)--Among the companies whose shares are expected to see active trading in Monday's session are Alcoa Inc., Tiffany & Co., and Burlington Stores Inc. Alcoa(AA) is projected to report fourth-quarter earnings of 27 cents a share, according to a consensus survey by FactSet.
Sign-up for 2015/1/11 - UPDATE: Alcoa, Tiffany, Burlington in Monday spotlight investment picks
2015/1/11
By Craig Stephen, MarketWatch Are Hutchison Whampoa shareholders getting a raw deal?
Sign-up for 2015/1/11 - Hong Kong tycoon Li Ka-shing restructures his empire investment picks
2015/1/11
GES looks forward to connecting with attendees through a variety of touchpoints LAS VEGAS , Jan.
Sign-up for 2015/1/11 - GES Has Big Plans For PCMA's Convening Leaders investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: 2015/1/12 - INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Alcobra, Ltd. to 2015/1/11 - GES Has Big Plans For PCMA's Convening Leaders
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent